<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0240">
 <label>47</label>
 <element-citation publication-type="journal" id="rf0230">
  <person-group person-group-type="author">
   <name>
    <surname>Anderson</surname>
    <given-names>E.J.</given-names>
   </name>
   <name>
    <surname>Carosone-Link</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Yogev</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Yi</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Simoes</surname>
    <given-names>E.A.F.</given-names>
   </name>
  </person-group>
  <article-title>Effectiveness of palivizumab in high-risk infants and children: a propensity score weighted regression analysis</article-title>
  <source>Pediatr Infect Dis J</source>
  <volume>36</volume>
  <issue>8</issue>
  <year>2017</year>
  <fpage>699</fpage>
  <lpage>704</lpage>
  <ext-link ext-link-type="uri" xlink:href="pmid:28709160" id="ir0315" xmlns:xlink="http://www.w3.org/1999/xlink">28709160</ext-link>
  <comment>PMCPMC5516669</comment>
  <pub-id pub-id-type="pmid">28709160</pub-id>
 </element-citation>
</ref>
